NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/12/2019
Back to search
Official data from USPTO
LECONTE MEDICAL CENTER COVENANT HEALTH.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
06/12/2019
Trademark type
Combined
Nice classes
44
Filing date
01/29/2008
Registration date
05/04/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/12/2019
Last transaction
06/12/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/14/2010
First use in commerce
02/14/2010
Drawing code
3
Owner type
03
Owner location
Knoxville, TN, US
Examiner
LE, KHANH M
Law office
M40
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a stylized cross with a stylized mountain range and stylized sun in the center. The stylized cross is not displayed in the color red or a colorable imitation thereof. Under the design element is the wording "LECONTE MEDICAL CENTER", underlined. Under that wording is the wording "COVENANT HEALTH", with a stylized letter "o". There is a period after the word "health."
Holders and representatives
Holders
C. H. (pessoa física)
Representatives
Andrew S. Neely Luedeka Neely Group, P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical services
Publications
History of USPTO decisions and trademark events.
41 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/12/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/12/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/12/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
05/06/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/04/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/23/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/23/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/23/2016
E815
TEAS SECTION 8 & 15 RECEIVED
04/19/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
05/04/2010
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/27/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
03/26/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/25/2010
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/20/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/19/2010
EX3G
SOU EXTENSION 3 GRANTED
03/19/2010
IUAF
USE AMENDMENT FILED
03/04/2010
EXT3
SOU EXTENSION 3 FILED
03/04/2010
EEXT
SOU TEAS EXTENSION RECEIVED
03/04/2010
EISU
TEAS STATEMENT OF USE RECEIVED
03/04/2010
EX2G
SOU EXTENSION 2 GRANTED
09/24/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/24/2009
EXT2
SOU EXTENSION 2 FILED
09/10/2009
EEXT
SOU TEAS EXTENSION RECEIVED
09/10/2009
EX1G
SOU EXTENSION 1 GRANTED
01/13/2009
EXT1
SOU EXTENSION 1 FILED
01/13/2009
EEXT
SOU TEAS EXTENSION RECEIVED
01/13/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
09/16/2008
PUBO
PUBLISHED FOR OPPOSITION
06/24/2008
NPUB
NOTICE OF PUBLICATION
06/04/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/19/2008
ALIE
ASSIGNED TO LIE
05/19/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/19/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
05/14/2008
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/14/2008
GNEA
EXAMINERS AMENDMENT E-MAILED
05/14/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/14/2008
DOCK
ASSIGNED TO EXAMINER
05/07/2008
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
02/05/2008
NWAP
NEW APPLICATION ENTERED
02/04/2008
Continuous trademark protection
Get notified about every new filing that threatens LECONTE MEDICAL CENTER COVENANT HEALTH. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.